Lucid Diagnostics Q4 Adj. EPS $(0.22) Down From $(0.19) YoY, Sales $300.00K

Lucid Diagnostics (NASDAQ:LUCD) reported quarterly losses of $(0.22) per share. This is a 15.79 percent decrease over losses of $(0.19) per share from the same period last year. The company reported $300.00 thousand in

Lucid Diagnostics (NASDAQ:LUCD) reported quarterly losses of $(0.22) per share. This is a 15.79 percent decrease over losses of $(0.19) per share from the same period last year. The company reported $300.00 thousand in sales this quarter.

Total
0
Shares
Related Posts